PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
-15.12%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$96.6M
AUM Growth
+$96.6M
(-21%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-20.06%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
115
New
5
Increased
36
Reduced
27
Closed
10
Top Buys
| 1 |
Magnite
MGNI
|
$999K |
| 2 |
Fortress Biotech
FBIO
|
$553K |
| 3 |
NeoGenomics
NEO
|
$408K |
| 4 |
SRXH
SRX Health Solutions, Inc.
SRXH
|
$379K |
| 5 |
Gryphon Digital Mining
GRYP
|
$300K |
Top Sells
| 1 |
ATRS
Antares Pharma, Inc.
ATRS
|
$1.97M |
| 2 |
LeMaitre Vascular
LMAT
|
$1.95M |
| 3 |
International Flavors & Fragrances
IFF
|
$563K |
| 4 |
AT&T
T
|
$235K |
| 5 |
Costco
COST
|
$219K |
Sector Composition
| 1 | Healthcare | 54.27% |
| 2 | Technology | 19.35% |
| 3 | Communication Services | 8.2% |
| 4 | Consumer Staples | 7.18% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$96.7B
| $1.27M | 1.32% |
16,508
| – | – |
|
27
CareDx
CDNA
$678M
| $1.26M | 1.3% |
58,492
+800
| +1% | +$17.2K |
|
28
Alphatec Holdings
ATEC
$2.35B
| $1.23M | 1.28% |
188,500
+14,000
| +8% | +$91.6K |
|
29
FlexShopper
FPAY
$17.9M
| $1.21M | 1.26% |
1,347,940
+5,500
| +0.4% | +$4.95K |
|
|
30
Magnite
MGNI
$3.49B
| $1.21M | 1.25% |
136,025
+112,500
| +478% | +$999K |
|
|
PDCO
31
DELISTED
Patterson Companies, Inc.
PDCO
| $1.13M | 1.17% |
37,200
-250
| -0.7% | -$7.57K |
|
32
Achieve Life Sciences
ACHV
$146M
| $1.11M | 1.15% |
228,100
+53,500
| +31% | +$261K |
|
33
Target
TGT
$42B
| $1.1M | 1.14% |
7,779
| – | – |
|
34
Merck
MRK
$210B
| $1.1M | 1.13% |
12,025
| – | – |
|
|
ASPU
35
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.07M | 1.1% |
1,087,375
-43,000
| -4% | -$42.2K |
|
|
EGIO
36
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.05M | 1.09% |
455,000
-500
| -0.1% | -$1.2K |
|
37
Gilead Sciences
GILD
$140B
| $965K | 1% |
15,617
-150
| -1% | -$9.27K |
|
38
Vericel Corp
VCEL
$1.69B
| $916K | 0.95% |
36,367
-1,200
| -3% | -$30.2K |
|
39
Perspective Therapeutics
CATX
$251M
| $901K | 0.93% |
2,914,500
+116,000
| +4% | +$35.9K |
|
40
Verizon
VZ
$184B
| $884K | 0.92% |
17,417
| – | – |
|
|
41
AT&T
T
$208B
| $871K | 0.9% |
41,537
+1,700
| +4% | -$235K |
|
|
AKTS
42
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $836K | 0.87% |
225,950
+31,500
| +16% | +$117K |
|
43
Ciena
CIEN
$13.4B
| $823K | 0.85% |
18,000
| – | – |
|
44
Journey Medical
DERM
$169M
| $823K | 0.85% |
220,050
+28,300
| +15% | +$106K |
|
45
3M
MMM
$81B
| $816K | 0.84% |
6,302
-104
| -2% | -$13.5K |
|
|
AUGX
46
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $791K | 0.82% |
439,500
+10,500
| +2% | +$18.9K |
|
47
MDxHealth
MDXH
$178M
| $755K | 0.78% |
90,458
+458
| +0.5% | +$3.82K |
|
48
Castle Biosciences
CSTL
$673M
| $728K | 0.75% |
33,170
| – | – |
|
|
49
Fortress Biotech
FBIO
$87.8M
| $639K | 0.66% |
760,992
+658,187
| +640% | +$553K |
|
50
ePlus
PLUS
$1.85B
| $637K | 0.66% |
12,000
| – | – |
|